• PetCanCure®

    PetCanCure®is applied to monitoring cancer recurrence and risk evaluation for post-op cancer dogs. By monitoring the variation of cancer genome in cell-free DNA (cfDNA) of post-op cancer dogs continually, equipping with big data and artificial intelligence, it evaluates cancer recurrence index (CRI).

    Product parameters

    Scope of application: Dogs with cancer who have undergone radical surgery

     

    Test indicators: Cancer Recurrence Index, CRI

     

    Sample requirements: 4ml of peripheral whole blood (non coagulation and hemolysis required)

     

    Detection cycle: 10 working days

     

    Detection significance: Significance of detection: The risk of cancer recurrence is monitored continuously and dynamically through postoperative blood, which realizes individualized postoperative management of dogs with cancer, and provides important clinical reference information for postoperative adjuvant treatment decision-making